SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-054692
Filing Date
2021-04-26
Accepted
2021-04-26 07:10:35
Documents
48
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcli-20210331x10q.htm   iXBRL 10-Q 882066
2 EXHIBIT 31.1 bcli-20210331xex31d1.htm EX-31.1 10502
3 EXHIBIT 31.2 bcli-20210331xex31d2.htm EX-31.2 10525
4 EXHIBIT 32.1 bcli-20210331xex32d1.htm EX-32.1 6283
5 EXHIBIT 32.2 bcli-20210331xex32d2.htm EX-32.2 6284
  Complete submission text file 0001104659-21-054692.txt   3082356

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcli-20210331.xsd EX-101.SCH 25332
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20210331_cal.xml EX-101.CAL 22994
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20210331_def.xml EX-101.DEF 61173
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20210331_lab.xml EX-101.LAB 196520
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20210331_pre.xml EX-101.PRE 160453
11 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20210331x10q_htm.xml XML 377516
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 21851535
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences